New CER tools grant payers the evidence they need to control drug costs
Edward Tuttle
Advertisement
Articles by Edward Tuttle
Advertisement
Latest Updated Articles
The Fruits of Comparative EffectivenessPublished: November 18th 2010 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
